rp-l201
Cell therapyexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2018 (NCT03812263)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- LymphocytesSupplementation
supplementation - lymphocytes
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03825783 | Phase 1 | Apr 15, 2019 | Hospital Infantil Universitario Niño Jesús, Madrid, Spain, Rocket Pharma Limited |
| NCT03812263 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2018 | California Institute for Regenerative Medicine (CIRM), Hospital Infantil Universitario Niño Jesús, Rocket Pharma Limited, University of California, Los Angeles |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Rocket Pharma Limited | For profit | 2 | 2 | 2 | 2018 |
| California Institute for Regenerative Medicine (CIRM) | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Hospital Infantil Universitario Niño Jesús | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Hospital Infantil Universitario Niño Jesús, Madrid, Spain | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of California, Los Angeles | Academic/Hospital | 1 | 0 | 1 | 2018 |
5 organizations
Page 1 / 1